Nurse Practitioner, Family · Melrose Park, IL
NPI
1760936090
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
675 W North Ave Ste 402
Melrose Park, IL, 60160
Phone (708) 450-4551
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
516 services
Medicare patients, 2024
66
Average age 67
Drug cost, 2024
$541K
1,431 prescriptions
Company payments, 2025
$73.44
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Genti Manco was code 90970 (esrd related services (not dialysis)), 208 times for 12 patients. In total Genti Manco billed 516 services in 12 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90970 ESRD Related Services (not dialysis) | Office | 208 | 12 | $6.48 | $1,348 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 38 | 30 | $184.16 | $6,998 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 17 | 15 | $135.17 | $2,298 |
By year: 2022 $18K for 4,723 services; 2023 $15K for 788 services; 2024 $15K for 516 services.
Medicare prescription drug claims, 2024
In 2024, the drug Genti Manco prescribed most often to Medicare patients was Sevelamer Carbonate, with 460 prescriptions and refills. In total Genti Manco wrote 1,431 Medicare prescriptions that cost $541K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 460 | 594 | 109 | $53K |
| Velphoro Sucroferric Oxyhydroxide | 111 | 131 | 27 | $246K |
| Calcium Acetate Generic | 52 | 61 | Under 11 | $3,018 |
| Nifedipine Er Nifedipine | 46 | 88 | 17 | $2,251 |
| Carvedilol Generic | 44 | 108 | 21 | $276 |
| Auryxia Ferric Citrate | 43 | 63 | 12 | $73K |
| Hydralazine Hcl Generic | 37 | 65 | 11 | $508 |
| Atorvastatin Calcium Generic | 32 | 55 | Under 11 | $240 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 31 | 35 | Under 11 | $553 |
| Renvela Sevelamer Carbonate | 30 | 40 | Under 11 | $54K |
| Lanthanum Carbonate Generic | 27 | 29 | Under 11 | $19K |
| Gabapentin Generic | 26 | 36 | Under 11 | $340 |
| Clopidogrel Clopidogrel Bisulfate | 25 | 43 | Under 11 | $205 |
| Pantoprazole Sodium Generic | 24 | 44 | Under 11 | $300 |
| Losartan Potassium Generic | 22 | 46 | Under 11 | $112 |
Brand drugs: 310 claims; generic drugs: 1,121 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Genti Manco $73.44 ($73.44 in general payments such as food, travel and fees) from 1 company. The largest payer was Fresenius USA Marketing, Inc. with $73.44.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 3 | $73.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.